Lesogaberan Completed Phase 2 Trials for Reflux Episodes Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT00743444
TLESR-impedance Study in Patients